KeelyE, BarbourL: Management of Diabetes in Pregnancy. 2014. www.endotext.org/chapter/diabetes-treatment-strategies/management-of-diabetes-in-pregnancy Accessed March28, 2016.
2.
CrowtherCA, HillerJE, MossJR, et al.: Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med, 2005; 352:2477–2486.
3.
CatalanoPM, McIntyreHD, CruickshankJK, et al.: The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care, 2012; 35:780–786.
4.
JensenDM, DammP, Moelsted-PedersenL, et al.: Outcomes in type 1 diabetic pregnancies: a nationwide, population-based study. Diabetes Care, 2004; 27:2819–2823.
5.
EversIM, de ValkHW, VisserGH: Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ, 2004; 328:915.
6.
MacintoshMC, FlemingKM, BaileyJA, et al.: Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ, 2006; 333:177.
7.
American Diabetes Association: 12. Management of diabetes in pregnancy. Diabetes Care, 2016; 39Suppl 1:S94–S98.
8.
Committee on Practice Bulletins – Obstetrics: Practice Bulletin No. 137: Gestational diabetes mellitus. Obstet Gynecol, 2013; 122(2 Pt 1):406–416.
9.
MathiesenER, KinsleyB, AmielSA, et al.: Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women. Diabetes Care, 2007; 30:771–776.
10.
HodM, DammP, KaajaR, et al.: Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects. Am J Obstet Gynecol, 2008; 198:186 e181–e187.
11.
LvS, WangJ, XuY: Safety of insulin analogs during pregnancy: a meta-analysis. Arch Gynecol Obstet, 2015; 292:749–756.
12.
MukhopadhyayA, FarrellT, FraserRB, OlaB: Continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant diabetic women: a systematic review and metaanalysis of randomized, controlled trials. Am J Obstet Gynecol, 2007; 197:447–456.
13.
LapollaA, DalfraMG, MasinM, et al.: Analysis of outcome of pregnancy in type 1 diabetics treated with insulin pump or conventional insulin therapy. Acta Diabetol, 2003; 40:143–149.
14.
CorduaS, SecherAL, RingholmL, et al.: Real-time continuous glucose monitoring during labour and delivery in women with type 1 diabetes—observations from a randomized controlled trial. Diabet Med, 2013; 30:1374–1381.
15.
SecherAL, RingholmL, AndersenHU, et al.: The effect of real-time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care, 2013; 36:1877–1883.
16.
PetrovskiG, DimitrovskiC, BogoevM, et al.: Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study. Diabetes Technol Ther, 2011; 13:1109–1113.
17.
MurphyHR, KumareswaranK, ElleriD, et al.: Safety and efficacy of 24-h closed-loop insulin delivery in well-controlled pregnant women with type 1 diabetes: a randomized crossover case series. Diabetes Care, 2011; 34:2527–2529.
18.
PolskyS, GiordanoD, VoelmleMK, et al.: Using technology to advance type 1 diabetes care among women during the reproductive years and in pregnancy. Postgrad Med, 2016:1–9.
19.
de VecianaM, MajorCA, MorganMA, et al.: Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med, 1995; 333:1237–1241.
20.
MareshMJ, HolmesVA, PattersonCC, et al.: Glycemic targets in the second and third trimester of pregnancy for women with type 1 diabetes. Diabetes Care, 2015; 38:34–42.
21.
BongiovanniM, FresaR, VisalliN, et al.: A study of the carbohydrate-to-insulin ratio in pregnant women with type1 diabetes on pump treatment. Diabetes Technol Ther, 2016; 18:360–365.
22.
KingJC, ButteNF, ChezRA, et al.: Summary. In: Nutrition During Pregnancy: Part I Weight Gain: Part II Nutrient Supplements. Washington (DC): National Academy Press; 1990:9–12.
23.
RoederHA, MooreTR, RamosGA: Insulin pump dosing across gestation in women with well-controlled type 1 diabetes mellitus. Am J Obstet Gynecol, 2012; 207:324 e321–e325.
24.
MurphyHR, ElleriD, AllenJM, et al.: Pathophysiology of postprandial hyperglycaemia in women with type 1 diabetes during pregnancy. Diabetologia, 2012; 55:282–293.
25.
GoudieRJ, LunnD, HovorkaR, MurphyHR.: Pharmacokinetics of insulin aspart in pregnant women with type 1 diabetes: every day is different. Diabetes Care, 2014; 37:e121–e122.